If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,504.00    -0.20 (-0.01%)
Bid:
1,505.80
Ask:
1,506.20
Spread: 0.40 (0.027%)
Market Cap: £124.65b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Statement re: Media Speculation

16 Sep 2020 17:37

RNS Number : 2278Z
Rolls-Royce Holdings plc
16 September 2020
Β 

16 September 2020

STATEMENT RE: MEDIA SPECULATION

Β 

Rolls-Royce notes the recent media speculation and, as we said at the half year results last month, we continue to review a range of funding options to further strengthen our balance sheet. These could include debt and equity but no final decisions have been taken.

Β 

We have already taken swift action to strengthen our liquidity with Β£6.1bn at the end of the first half of the year and a further Β£2bn term loan agreed in the second half. We have also announced Β£1bn of cost mitigation activity in 2020 and launched a reorganisation of our Civil Aerospace business to save Β£1.3bn annually. We have also identified a number of potential disposals that are expected to generate proceeds of more than Β£2bn over the next 18 months, including ITP Aero.

Β 

A further announcement will be made if and when appropriate.

Β 

Β 

About Rolls-Royce Holdings plc

Β 

1. Rolls-Royce pioneers cutting-edge technologies that deliver clean, safe and competitive solutions to meet our planet's vital power needs.Β 

2. Rolls-Royce has customers in more than 150 countries, comprising more than 400 airlines and leasing customers, 160 armed forces, 70 navies, and more than 5,000 power and nuclear customers.

3. Annual underlying revenue was Β£15.45 billion in 2019, around half of which came from the provision of aftermarket services.

4. In 2019, Rolls-Royce invested Β£1.46 billion on research and development. We also support a global network of 29 University Technology Centres, which position Rolls-Royce engineers at the forefront of scientific research.

5. Rolls-Royce Holdings plc LEI: 213800EC7997ZBLZJH69Β 

Β 

Β 

For further information, please contact:

Β Media

Richard Wray

Director of External Communications & Brand, Rolls-Royce plc

Tel +44 (0) 7810 850055

Richard.Wray@Rolls-Royce.com

Β 

Sarah Jones

Head of Campaigns - External Communications

Tel +44 (0)7968 906 469

sarah.jones2@rolls-royce.com

Β Investors

Isabel Green

Head of Investor Relations, Rolls-Royce plc

Tel +44 (0) 7880 160976

Isabel.Green@Rolls-Royce.com

Β 

www.Rolls-Royce.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
SPCUNONRRVUKAAR
Date   Source Headline
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20254:30 pmRNSDirector/PDMR Shareholding
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 202512:00 pmRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20251:00 pmRNSDirector/PDMR Shareholding
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20253:00 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20255:00 pmRNSHolding(s) in Company
11th Mar 20259:30 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20259:02 amRNSAGM Statement
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20253:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20259:37 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:05 amRNSShare buyback programme of up to £1 billion
27th Feb 20257:00 amRNSFull Year Results 2024
10th Feb 20252:30 pmRNSDirector/PDMR Shareholding
4th Feb 20253:30 pmRNSTotal Voting Rights
28th Jan 202511:30 amRNSDirector/PDMR Shareholding
9th Jan 202511:30 amRNSDirector/PDMR Shareholding
11th Dec 202410:00 amRNSDirector/PDMR Shareholding
22nd Nov 20241:00 pmRNSDirector Declaration
11th Nov 20241:30 pmRNSDirector/PDMR Shareholding
7th Nov 20247:00 amRNSTrading Update
9th Oct 20249:05 amRNSDirector/PDMR Shareholding
26th Sep 202412:00 pmRNSDirector/PDMR Shareholding
16th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20249:15 amRNSDirector/PDMR Shareholding
28th Aug 20242:05 pmRNSDirector/PDMR Shareholding
16th Aug 20241:30 pmRNSDirector/PDMR Shareholding
9th Aug 202411:15 amRNSDirector/PDMR Shareholding
2nd Aug 20249:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.